Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT01860651
Eligibility Criteria:
Inclusion Criteria:
* IBD diagnosis according to the Copenhagen and Porto criteria
* Aged between 10-17 years
* Fluent in Danish
* Access to the internet
* Patients in treatment with infliximab must have completed the induction period (i.e. minimum six week after start-up of treatment).
Exclusion Criteria:
* Insufficient Danish language skills
* Lack of intellectual capacity
* Growth retardation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
17 Years
Study:
NCT01860651
Study Brief:
Protocol Section:
NCT01860651